(d) DAG and ceramide, which are downregulated after Wnt3a treatment in HCC cells' plasma membrane, enhance Wnt/β‐catenin signaling activity in SNU475 and HepG2 cells. Here, WNT3A is linked to hepatocellular carcinoma.